Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01516307 | Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects | completed | Phase 2 | 349 | OBI Pharma, IncINDUSTRY | 5 | Sep 16, 2020 | clinicaltrials |
| NCT02402764 | Phase 2 Trial of Selinexor (KPT-330) for Metastatic Triple Negative Breast Cancer (TNBC) | completed | Phase 2 | 10 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 11, 2020 | clinicaltrials |
| NCT00068341 | Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer | completed | Phase 2 | 74 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 9, 2020 | clinicaltrials |
| NCT00562718 | Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery | completed | Phase 2 | 50 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 21, 2020 | clinicaltrials |
| NCT00006682 | Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Medstar Health Research InstituteOTHER | 1 | Aug 14, 2020 | clinicaltrials |
| NCT00217672 | Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer | completed | Phase 2 | 76 | Translational Oncology Research InternationalOTHER | 1 | Aug 5, 2020 | clinicaltrials |
| NCT01276041 | Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer | completed | Phase 2 | 70 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT04496492 | Preoperative Use of Tocotrienol From Annatto Bixa Orellana L. in Breast Cancer Patients: a Prospective Clinical Trial.(TOCANNATO) | completed | Phase 2 | 50 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT02344550 | Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer(LEO) | completed | Phase 2 | 137 | Asan Medical CenterOTHER | 1 | Jul 30, 2020 | clinicaltrials |
| NCT02581839 | Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate | completed | Phase 2 | 9 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 30, 2020 | clinicaltrials |
| NCT04002284 | Anlotinib in Metastatic HER2 Negative Breast Cancer | completed | Phase 2 | 26 | Peng YuanUNKNOWN | 1 | Jul 29, 2020 | clinicaltrials |
| NCT00206518 | Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients(TACAC) | completed | Phase 2 | 167 | Mothaffar RimawiOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT00570323 | Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer(PACT001) | completed | Phase 2 | 72 | Mothaffar RimawiOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT03140553 | TCH Versus EC-TH as Neoadjuvant Treatment for HER2-Positive Breast Cancer(neoCARH) | completed | Phase 2 | 140 | Guangdong Provincial People's HospitalOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT00054301 | Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast Cancer | completed | Phase 2 | 2 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 27, 2020 | clinicaltrials |
| NCT00253500 | Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer | completed | Phase 2 | 15 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 24, 2020 | clinicaltrials |
| NCT01908101 | Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast Cancer | completed | Phase 2 | 86 | University of WashingtonOTHER | 1 | Jul 23, 2020 | clinicaltrials |
| NCT00123669 | Primary Progesterone Therapy for Operable Breast Cancer | completed | Phase 2 / Phase 3 | 1,000 | Tata Memorial HospitalOTHER_GOV | 1 | Jul 22, 2020 | clinicaltrials |
| NCT01596751 | Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 67 | Hope Rugo, MDOTHER | 1 | Jul 17, 2020 | clinicaltrials |
| NCT02362958 | A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer | completed | Phase 2 | 159 | Sun Yat-sen UniversityOTHER | 1 | Jul 15, 2020 | clinicaltrials |
| NCT02530424 | "Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment "(NA-PHER2) | completed | Phase 2 | 102 | Fondazione MichelangeloOTHER | 1 | Jul 15, 2020 | clinicaltrials |
| NCT02263495 | Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer(EG_PG) | completed | Phase 2 | 118 | Asan Medical CenterOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT04072718 | Simultaneous Integrated Boost With Volumetric Arc Radiotherapy in Patients With Breast Cancer(SIBART-BC) | completed | Phase 2 | 27 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT03183206 | Safety and Efficiency of γδ T Cell Against Breast Cancer | completed | Phase 1 / Phase 2 | 100 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jul 13, 2020 | clinicaltrials |
| NCT01466972 | Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib | completed | Phase 2 | 30 | Hope Rugo, MDOTHER | 1 | Jul 8, 2020 | clinicaltrials |
| NCT02544997 | A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway | completed | Phase 2 | 5 | Samsung Medical CenterOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT02628132 | Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients | completed | Phase 1 / Phase 2 | 22 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT02441946 | A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer(neoMONARCH) | completed | Phase 2 | 224 | Eli Lilly and CompanyINDUSTRY | 10 | Jun 17, 2020 | clinicaltrials |
| NCT00617942 | Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer | completed | Phase 2 | 60 | William Sikov MDOTHER | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04418089 | Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer | completed | Phase 2 | 60 | Indonesia UniversityOTHER | 1 | Jun 5, 2020 | clinicaltrials |
| NCT01446159 | Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer | completed | Phase 2 | 188 | MedImmune LLCINDUSTRY | 11 | Jun 2, 2020 | clinicaltrials |
| NCT01792050 | Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer | completed | Phase 2 | 169 | NewLink Genetics CorporationINDUSTRY | 2 | May 28, 2020 | clinicaltrials |
| NCT00295867 | Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer | completed | Phase 2 | 45 | University of California, San FranciscoOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT00399529 | Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer | completed | Phase 2 | 22 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Apr 22, 2020 | clinicaltrials |
| NCT02455154 | Traditional Chinese Medicine as Preventive Method for Osteoporosis Induced by Adjuvant Endocrine Therapy(COAT) | completed | Phase 2 | 278 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT02061332 | DC Vaccine for Patients With Ductal Carcinoma In Situ(DCIS6) | completed | Phase 1 / Phase 2 | 58 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 10, 2020 | clinicaltrials |
| NCT00472693 | Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer | completed | Phase 2 | 5 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 9, 2020 | clinicaltrials |
| NCT00238316 | Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density | completed | Phase 2 | 68 | NCIC Clinical Trials GroupNETWORK | 2 | Apr 2, 2020 | clinicaltrials |
| NCT01855828 | Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer | completed | Phase 2 | 50 | Yale UniversityOTHER | 1 | Mar 31, 2020 | clinicaltrials |
| NCT00524277 | Vaccine Therapy in Treating Patients With Breast Cancer | completed | Phase 2 | 456 | San Antonio Military Medical CenterFED | 3 | Mar 30, 2020 | clinicaltrials |
| NCT00684983 | Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Mar 24, 2020 | clinicaltrials |
| NCT01034215 | Multi-Media Imagery Program for Breast Cancer Patients (Phase II) | completed | Phase 2 | 135 | Mind Matters Research LLCOTHER | 1 | Mar 10, 2020 | clinicaltrials |
| NCT02866955 | Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.(EFESE) | completed | Phase 2 | 100 | Institut de Cancérologie de LorraineOTHER | 1 | Mar 9, 2020 | clinicaltrials |
| NCT02067351 | Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy | completed | Phase 2 | 6 | Mayo ClinicOTHER | 1 | Mar 3, 2020 | clinicaltrials |
| NCT02048059 | ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases | completed | Phase 2 | 72 | Angiochem IncINDUSTRY | 1 | Feb 25, 2020 | clinicaltrials |
| NCT00376688 | Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | 31 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2020 | clinicaltrials |
| NCT00262834 | Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer | completed | Phase 2 | 54 | National Cancer Institute (NCI)NIH | 1 | Feb 19, 2020 | clinicaltrials |
| NCT00278109 | Partial Breast Irradiation With Chemotherapy | completed | Phase 1 / Phase 2 | 27 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 19, 2020 | clinicaltrials |
| NCT00602043 | F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer | completed | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | Feb 19, 2020 | clinicaltrials |
Data updated 24 days agoSource updated Sep 16, 2020source: clinicaltrials